CEA recommends pricing reforms at home and abroad
The Council of Economic Advisers issued a white paper proposing ways that the U.S. government can reduce drug prices while also fostering innovation. The paper included recommendations to reform policies that hinder price competition at home and implement policies to limit "free-riding" abroad.
The group said ex-U.S. drug developers and governments rely on U.S. patients and tax payers to finance R&D. It said that because most ex-U.S. governments -- as their...
Read the full 361 word article
User Sign in
Trial Subscription
Get a 4-week free trial subscription to BioCentury Extra
Article Purchase
$35 USD
